Open AccessInfluence of CYP2C9*2 genetic polymorphism on pharmacokinetics of losartan and its active metabolite E-3174 on the background of CYP3A4 wild genotype in healthy Chinese Hui subjects
Author(s) -
杨璐,
郭涛,
庄雪梅,
顾红燕
Publication year - 2018
Publication title -
journal of chinese pharmaceutical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.138
H-Index - 12
ISSN - 1003-1057
DOI - 10.5246/jcps.2018.01.002
Subject(s) - cyp2c9 , pharmacokinetics , genotype , active metabolite , losartan , pharmacogenetics , cyp3a4 , metabolite , polymorphism (computer science) , cyp3a5 , pharmacology , medicine , genetics , biology , gene , cytochrome p450 , angiotensin ii , receptor , metabolism